Last update: Oct. 9, 2016

Levocabastine Hydrochloride

Very Low Risk for breastfeeding


Safe. Compatible.
Not risky for breastfeeding or infant.

Antihistamine for topical use both on nose and eye.

Plasma concentrations reached are very low and, according to the manufacturer, it is excreted into breastmilk in clinically non-significant amount at 0.3 to 0.6% of maternal dose: 1.5 to 3 micrograms.

As in most ophthalmic and nasal topically used preparations, the tiny dose and poor levels in the blood, render it compatible with breastfeeding.

Alternatives

We do not have alternatives for Levocabastine Hydrochloride since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Levocabastine Hydrochloride in other languages or writings:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. Oft 30-60. Nas 60-80 %
Molecular weight 457 daltons
Protein Binding 55 %
VD 1,2 l/Kg
Tmax 2 hours
T1/2 35 - 40 hours

References

  1. AEMPS. Levocabastina Nasal. Ficha técnica. 2016 Full text (in our servers)
  2. AEMPS. Levocabastina oftálmica. Ficha técnica. 2016 Full text (in our servers)
  3. J & J. Levocabastine. Drug Summary. 2010 Full text (in our servers)

Total visits

6,769

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM